Shares of Omron Corp. (OTCMKTS:OMRNY – Get Free Report) gapped down prior to trading on Thursday. The stock had previously closed at $41.11, but opened at $37.3650. Omron shares last traded at $37.40, with a volume of 2,155 shares.
Wall Street Analyst Weigh In
Separately, Zacks Research raised Omron from a “strong sell” rating to a “hold” rating in a report on Monday, August 10th. Two equities research analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Omron presently has a consensus rating of “Hold”.
Check Out Our Latest Research Report on Omron
Omron Stock Down 5.6%
The company’s 50 day simple moving average is $40.57 and its 200-day simple moving average is $36.48. The company has a current ratio of 1.93, a quick ratio of 1.49 and a debt-to-equity ratio of 0.09. The firm has a market cap of $7.74 billion, a P/E ratio of 35.72, a PEG ratio of 0.80 and a beta of 1.22.
Institutional Inflows and Outflows
A hedge fund recently raised its position in Omron stock. GAMMA Investing LLC boosted its stake in shares of Omron Corp. (OTCMKTS:OMRNY – Free Report) by 12.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,536 shares of the company’s stock after purchasing an additional 382 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $144,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 1.09% of the company’s stock.
Omron Company Profile
Omron Corporation is a Japan-based technology company that develops automation, sensing, control and healthcare solutions. Its products include industrial sensors, controllers, machine-vision and inspection systems, safety equipment, robotics and other factory-automation technologies used to improve manufacturing productivity and quality.
Through its healthcare business, Omron provides blood-pressure monitors, electrocardiographs, nebulizers, body-composition monitors and related digital health services for consumers and medical professionals.
Further Reading
- Five stocks we like better than Omron
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
- Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
- Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.
